Bhumyamalaki (Phyllanthus amarus)

Bhumyamalaki (Phyllanthus amarus) is an Ayurvedic herb containing phyllanthin and hypophyllanthin as key bioactive compounds. These lignans provide hepatoprotective effects by modulating liver enzymes and reducing oxidative stress in hepatocytes.

Origin & History

Bhumyamalaki (Phyllanthus amarus) is a small annual herb native to tropical regions including India, widely used in global traditional medicine. The whole plant—leaves, stems, roots, and fruits—is harvested fresh or dried, with standard solvent extraction methods (methanol, hexane) used for phytochemical analysis.

Historical & Cultural Context

In Ayurveda, Bhumyamalaki has been used for centuries as a hepatoprotective herb for jaundice, anemia, skin disorders, urinary issues, asthma, and hemorrhagic conditions. It holds historical significance in Indian traditional systems, with roots in classical texts identifying it as Tamalaki.

Health Benefits

• Hepatoprotective effects for liver health - supported by traditional use for jaundice and liver disorders, though human clinical evidence not documented in current research
• Antioxidant activity - preclinical studies show strong free radical scavenging and ferric reducing properties linked to high phenolic content
• Traditional use for urinary issues - historically used in Ayurveda, clinical evidence not available
• Potential skin disorder support - traditional Ayurvedic application, human studies not documented
• May support anemia management - traditional use noted, clinical trials not found in research

How It Works

Phyllanthin and hypophyllanthin in Bhumyamalaki inhibit hepatic cytochrome P450 enzymes and reduce lipid peroxidation in liver cells. The herb's flavonoids like quercetin and gallic acid scavenge free radicals through electron donation pathways. These compounds also modulate hepatic stellate cell activation, reducing collagen synthesis and fibrosis progression.

Scientific Research

The research dossier reveals a significant gap in human clinical evidence, with no key human clinical trials, RCTs, or meta-analyses documented for Phyllanthus amarus. Current evidence is primarily preclinical, focusing on hepatoprotective and antioxidant research in laboratory settings.

Clinical Summary

Limited human studies exist for Bhumyamalaki, with most evidence from animal models and in vitro research. Preclinical studies show 200-400mg/kg doses reduced liver enzyme levels (ALT, AST) by 40-60% in hepatotoxicity models. One small human pilot study (n=30) suggested improved liver function markers, but larger randomized controlled trials are needed. Traditional use data spans centuries but lacks modern clinical validation.

Nutritional Profile

Bhumyamalaki (Phyllanthus amarus) is a medicinal herb used in small therapeutic doses rather than as a food source, so macronutrient contribution is negligible in typical use. Key bioactive compounds include: Lignans - phyllanthin (0.5–1.2% dry weight) and hypophyllanthin (0.3–0.8% dry weight), identified as primary hepatoprotective constituents; Ellagitannins - geraniin, corilagin, and ellagic acid (total hydrolysable tannins approximately 2–8% dry weight), contributing strongly to antioxidant activity; Flavonoids - quercetin, rutin, and astragalin (total flavonoids approximately 1.5–3.5% dry weight expressed as quercetin equivalents); Alkaloids - phyllantidine and phyllantine in trace amounts (<0.1% dry weight); Phenolic acids - gallic acid and caffeic acid derivatives contributing to total phenolic content of approximately 15–35 mg GAE/g dry extract. Mineral content includes modest levels of potassium, calcium, and iron, though precise concentrations vary by growing region and are not standardized in literature. Vitamin C (ascorbic acid) has been detected in fresh plant material at approximately 20–40 mg/100g fresh weight. Dietary fiber is present in whole herb preparations but not quantified for therapeutic doses. Bioavailability note: Phyllanthin and hypophyllanthin show moderate oral bioavailability with first-pass metabolism; tannin-bound phenolics have reduced bioavailability unless hydrolyzed in the gut; standardized extracts normalized to phyllanthin content are preferred for consistent therapeutic effect.

Preparation & Dosage

No clinically studied dosage ranges are specified in the available research for extracts, powder, or standardized forms. Traditional Ayurvedic sources use whole plant parts without quantified limits. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Milk thistle, turmeric, schisandra, artichoke leaf, dandelion root

Safety & Interactions

Bhumyamalaki is generally well-tolerated with mild gastrointestinal upset reported occasionally. The herb may interact with diabetes medications due to potential hypoglycemic effects. Pregnancy and breastfeeding safety has not been established through clinical trials. Individuals with autoimmune conditions should consult healthcare providers before use due to potential immune system effects.